BRAF and MEK Inhibitors and Their Toxicities: A Meta-Analysis.

Mattia GaruttiMelissa BergnachJerry Polesel Lorenza PalmeroMaria Antonietta PizzichettaFabio Puglisi

Published in: Cancers (2022)

Our study provides comprehensive data on treatment-related adverse events of BRAFi and MEKi combination therapies, showing related toxicity profiles to offer a helpful tool for clinicians in the choice of therapy.

Keyphrases

palliative care
electronic health record
stem cells
big data
pi k akt
deep learning
combination therapy
cell therapy
metastatic colorectal cancer